Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Splanchnic vein thrombosis].
Gouin B, Robert-Ebadi H, Casini A, Beauverd Y, Fontana P, Righini M, Elkrief L. Gouin B, et al. Among authors: beauverd y. Rev Med Suisse. 2017 Dec 6;13(586):2138-2143. Rev Med Suisse. 2017. PMID: 29211374 French.
[Monitoring of heparins and of anticoagulants].
Beauverd Y, Boehlen F, Fontana P, Louis-Simonet M. Beauverd Y, et al. Rev Med Suisse. 2011 Oct 19;7(313):2014-7. Rev Med Suisse. 2011. PMID: 22073696 French.
Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletion.
Beauverd Y, Roosnek E, Tirefort Y, Nagy-Hulliger M, Bernimoulin M, Tsopra O, Ansari M, Dantin C, Casini A, Grandjean AP, Chigrinova E, Masouridi-Levrat S, Chalandon Y. Beauverd Y, et al. Biol Blood Marrow Transplant. 2014 Sep;20(9):1322-8. doi: 10.1016/j.bbmt.2014.04.023. Epub 2014 Apr 24. Biol Blood Marrow Transplant. 2014. PMID: 24769318 Free article.
Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants.
Masouridi-Levrat S, Simonetta F, Beauverd Y, Tsopra O, Tirefort Y, Stephan C, Levrat E, Ansari M, Verholen F, Roosnek E, Passweg JR, Chalandon Y. Masouridi-Levrat S, et al. Among authors: beauverd y. Bone Marrow Transplant. 2016 Jun;51(6):860-2. doi: 10.1038/bmt.2015.356. Epub 2016 Feb 8. Bone Marrow Transplant. 2016. PMID: 26855156 No abstract available.
Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk index.
Beauverd Y, Roosnek E, Tirefort Y, Dantin C, Ansari M, Tsopra O, Masouridi-Levrat S, Chalandon Y. Beauverd Y, et al. Bone Marrow Transplant. 2016 Jul;51(7):955-60. doi: 10.1038/bmt.2016.34. Epub 2016 Mar 7. Bone Marrow Transplant. 2016. PMID: 26950373 Free article.
Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation.
Simonetta F, Masouridi-Levrat S, Beauverd Y, Tsopra O, Tirefort Y, Koutsi A, Stephan C, Polchlopek-Blasiak K, Pradier A, Dantin C, Ansari M, Roosnek E, Chalandon Y. Simonetta F, et al. Among authors: beauverd y. Leuk Lymphoma. 2018 Mar;59(3):590-600. doi: 10.1080/10428194.2017.1344844. Epub 2017 Jul 6. Leuk Lymphoma. 2018. PMID: 28679328
26 results